In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study
Research output: Contribution to journal › Journal article › Research › peer-review
Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.
| Original language | English |
|---|---|
| Journal | Journal of Hypertension |
| Volume | 28 |
| Issue number | 7 |
| Pages (from-to) | 1541-6 |
| Number of pages | 6 |
| ISSN | 0263-6352 |
| DOIs | |
| Publication status | Published - 1 Jul 2010 |
ID: 34130747